![]() |
市场调查报告书
商品编码
1746834
日本血栓切除设备市场报告(按产品类型、应用、最终用户和地区)2025 年至 2033 年Japan Thrombectomy Devices Market Report by Product Type, Application, End User, and Region 2025-2033 |
2024年,日本血栓切除设备市场规模达5,390万美元。展望未来, IMARC Group预计到2033年,该市场规模将达到9,570万美元,2025-2033年期间的复合年增长率(CAGR)为6.27%。人口结构变化、技术进步以及对微创医疗的重视是推动市场发展的关键因素。
血栓切除装置在替代终点方面具有一系列优势,包括生物标记分析、梗塞面积缩小、ST 段回撤改善以及心肌梗塞血管造影溶栓 (TIMI) 血流增强等。这些装置旨在最大限度地减少失血量,并最大程度地减少医疗操作过程中对血管壁的损伤。因此,它们可用于治疗静脉、动脉和毛细血管内的血栓。此外,它们还可用于治疗肺栓塞和周边动脉疾病等疾病。目前,血栓切除装置有各种尺寸和直径,可根据特定治疗区域进行客製化。最常用的血栓切除术包括球囊栓塞切除术、手术栓塞切除术和抽吸栓塞切除术。
日本血栓切除器械市场正经历显着成长,这主要得益于几个关键因素。其中一个主要驱动因素是老年人口中血管疾病(包括週边动脉疾病和静脉血栓栓塞症)的盛行率不断上升。随着日本老龄人口不断增长,对有效的血栓切除手术和器械的需求也日益增长。此外,日本的医疗保健领域也非常重视微创手术。血栓切除器械能够以微创的方式处理血栓和阻塞,与此趋势完美契合。越来越多的患者和医护人员选择能够最大程度减少创伤、缩短住院时间和加速康復的手术,这进一步推动了血栓切除器械的普及。日本先进的医疗基础设施和技术实力也在血栓切除器械市场的成长中发挥关键作用。该国在医学研究和创新方面处于领先地位,引领先进血栓切除术技术的发展。此外,医护人员和患者对及时进行血栓切除术的益处(例如降低发病率和改善生活品质)的认识不断提高,这有望在未来几年持续增长。
市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争指标和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
Japan thrombectomy devices market size reached USD 53.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 95.7 Million by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. Demographic shifts, technological advancements, and a commitment to minimally invasive healthcare represent some of the key factors driving the market.
Thrombectomy devices offer a range of advantages when it comes to surrogate endpoints, encompassing factors like biomarker analysis, reduction in infarct size, improved ST-segment resolution, and enhanced angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices are designed to minimize blood loss and minimize damage to the vessel wall during medical procedures. As a result, they have applications in the treatment of blood clots within veins, arteries, and capillaries. Additionally, they are employed in addressing conditions such as pulmonary embolism and peripheral arterial diseases. Thrombectomy devices are currently available in various sizes and diameters, tailored to the specific area requiring treatment. Among the most commonly utilized thrombectomy procedures are balloon embolectomy, surgical embolectomy, and aspiration embolectomy.
The thrombectomy devices market in Japan is experiencing notable growth, driven by several key factors. One of the primary drivers is the increasing prevalence of vascular diseases, including peripheral arterial diseases and venous thromboembolism, within the aging population. As Japan grapples with a growing elderly demographic, the demand for effective thrombectomy procedures and devices is on the rise. Furthermore, there is a significant emphasis on minimally invasive procedures in the country's healthcare landscape. Thrombectomy devices, with their ability to address blood clots and blockages in a less invasive manner, align perfectly with this trend. Patients and healthcare professionals alike are increasingly opting for procedures that minimize trauma, reduce hospital stays, and expedite recovery, further boosting the adoption of thrombectomy devices. Japan's advanced healthcare infrastructure and technological prowess also play a pivotal role in the growth of the thrombectomy devices market. The country is at the forefront of medical research and innovation, leading to the development of advanced thrombectomy technologies. Additionally, increasing awareness among both healthcare providers and patients about the benefits of timely thrombectomy procedures, such as reduced morbidity and improved quality of life, is poised for continued growth in the coming years.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.